Study Title definition
Study Title. Set-Up and Pre-Validation of an HPLC Method for the Determination of BA058 and PTH in Dose Formulations SCOPE OF WORK DATED: November 14, 2008 PRICE: $1,900 US/Day (as per Study Authorization dated February 9, 2009) PAYMENT TERMS: · Monthly billing as per work performed. PROPOSED COMMENCEMENT OF WORK: February 2009 PROPOSED REPORTING TIME: Not applicable ACCLIMATION PERIOD: Not applicable RETENTION PERIOD: One (1) year STUDY MATERIAL STORAGE/ARCHIVES. After dispatch of the draft report, all raw data, samples/specimens (except for those sent to Sponsor or Sponsor designated laboratory and resultant data which are the responsibility of Sponsor) and documents generated at ▇▇▇▇▇▇▇ River Montreal during this study, together with the original copy of the protocol (including amendments) and the draft report, will be retained in the secure storage area of ▇▇▇▇▇▇▇ River Montreal for one (1) year at no charge. After this one (1’) year period, Sponsor will be contacted prior to the end of the year to authorize continued storage or return to Sponsor, at additional cost. At finalisation, the final report and any stored materials will be transferred to the scientific archives of ▇▇▇▇▇▇▇ River Montreal. Subsequently, storage details will be documented in the raw data. Any additional storage, archiving or retention will require an Extended Archiving Agreement DELAY IN PRECLINICAL WORK. In the event that any animals are purchased by ▇▇▇▇▇▇▇ River Montreal, as authorized by and on behalf of the Sponsor, for preclinical work to be performed under this Letter of Agreement, the parties hereto agree that the acclimation period (“Acclimation Period”) shall be stipulated herein. After the completion of the Acclimation Period, should there be any delay in the commencement of the Study that is attributable to the Sponsor, in any way, then the Sponsor agrees to reimburse housing fees to ▇▇▇▇▇▇▇ River Montreal for the said delay at rates prevailing at the time of said delay.
Study Title. [Insert SHORT TITLE OF STUDY] Reference: [Insert REFERENCE NUMBER e.g. IRAS, EUDRACT NUMBER OR SIMILAR REFERENCE]
Study Title. Validation of an HPLC Method for the Determination of BA058 and PTH in Dose Formulations SCOPE OF WORK DATED: To be provided PRICE: $21,850 US (as per Study Authorization dated February 9, 2009) PAYMENT TERMS: 50% - $10,925 US - 1st installment at commencement of laboratory work 50% - $10,925 US - 2nd installment at completion of laboratory work (excluding long term stability testing, if applicable) PROPOSED COMMENCEMENT OF WORK: March 2009
Examples of Study Title in a sentence
Study Title: Please include the same title that you used in iProtocol.
Notification shall be in writing either electronic or by mail: Study Title: TRACK-TBI University of California, San Francisco Department of Neurological Surgery Brain and Spinal Injury Center ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇.
Study Title A ▇▇▇▇▇ ▇/▇▇, ▇▇▇▇-▇▇▇▇▇, Multicenter, Repeat-Dose, Dose-Selection Study of CPI-444 as Single Agent and in Combination with Atezolizumab in Patients with Selected Incurable Cancers Protocol Number CPI-444-001 Development ▇▇▇▇▇ ▇▇▇▇▇ ▇ IND Number 126,559 Drug Substance Adenosine-2A (A2A) Receptor Antagonist CPI-444 [***] Indication Treatment of patients with selected incurable cancers Medical Monitor [***] Vice President of Clinical Development Corvus Pharmaceuticals, Inc.
Drug: CHS-0214 Versus Enbrel® Study ID: CHS-0214-02 Study Title: A ▇▇▇▇▇ ▇, ▇▇▇▇▇▇-▇▇▇▇▇, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel® in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment with Methotrexate CRO Name: Medpace CRO Address: ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ OBLIGATIONS TRANSFERRED TO MEDPACE: x THE APPROPRIATE BOX(ES).
Notwithstanding anything herein to the contrary, Subrecipient shall have the right to post PTE’s name, the Study Title, and the Period of Performance, and funding amount, on Subrecipient publicly accessible lists of research conducted by the Subrecipient.
More Definitions of Study Title
Study Title. Screen hENT1 antibody for suitability on Ventana’s automated system. • Study Identification: Clovis hENT1 BIOMARKER PROJECT
Study Title. IRB #: The above-named Unaffiliated Investigator has reviewed the Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research; the U.S. Department of Health and Human Services (DHHS) regulations for the protection of human subjects at 45 CFR 46, the Assurance referenced above, and the relevant institutional policies and procedures for the protection of human subjects.
Study Title. [TITLE] [SPONSOR_PROTOCOLS] It is your responsibility to:
Study Title. A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects with Hypertension Requiring Antihypertensive Therapy PROTOCOL NO.: K-302-03-01 I. Regulatory and Ethics
Study Title. The evolutionary ecology ofLupinus lepidus Abstract: A four year study of the evolutionary consequences of colonization was begun in 1990. The objectives of this study are to document the pattern of genetic variation in a colonizing plant species, Lupinus lepidus, and investigate the ecological processes which are expected to affect that pattern. Preliminary genetic data indicate that colonies ofL. lepidus on the pumice plain of Mount St. Helens are genetically different from each other, probably due to the differing genetic composition of founders. Whether or not differentiation due to founder effects will persist depends on: 1) the rate of population growth, 2) the level of migration between popu- lations, 3) the rate of self-fertilization, and 4) spatial variability in natural selection. Efforts are underway to assess the importance of each of these processes. Population growth rate and factors affecting it, such as herbivory, are being studied by measuring survivorship, fecundity, seed bank properties, and other demographic parameters for a large number of natural and experimental populations. Genetic studies of these populations arc underway which will allow a comparison of genetic drift with population growth. Preliminary data shows thatL. lepidus is self-compatible and that colonizing populations may exhibit a high level of self- fertilization due to the absence of pollinators. This will tend to increase differentiation between populations. The relationship between fruit set and flowering time was studied in seven populations for two years. This data indicates strong natural selection which varies among populations. However, the observation that selection also varies within populations among years is expected to counteract the among population effects. Much of the variation among popula- tions and years is due to variation in herbivore loads and possibly to pollinator visitation. Reciprocal transplants between populations, started in 1991, will reveal population differentiation and the genetic basis for character differences.
Study Title. An Open-Label, Multicenter, Phase 1/2 Trial of GEN3014 (HexaBody®-CD38) in Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies Název studie: Otevřené multicentrické klinické hodnocení fáze 1/2 přípravku GEN3014 (HexaBody®-CD38) u relabujícího nebo refrakterního mnohočetného myelomu a dalších hematologických malignit
Study Title. “A PHASE 1B/2, OPEN-LABEL TRIAL TO ASSESS THE SAFETY AND PRELIMINARY EFFICACY OF EPCORITAMAB (GEN3013; DUOBODY® CD3XCD20) IN COMBINATION WITH OTHER AGENTS IN SUBJECTS WITH B-CELL NON-HODGKIN LYMPHOMA” Název klinického hodnocení: „OTEVŘENÉ KLINICKÉ HODONCENÍ FÁZE 1B/2 POSUZUJÍCÍ BEZPEČNOST A PŘEDBĚŽNOU ÚČINNOST EPCORITAMABU (GEN3013; DUOBODY, CD3XCD20) V KOMBINACI S DALŠÍMI PŘÍPRAVKY U PACIENTŮ S B- BUNĚČNÝM NON-HODGKINOVÝM LYMFOMEM“ Protocol no.: GCT3013-02 Č. protokolu: GCT3013-02